With over a decade of experience in venture capital, the fund manager has successfully navigated various investment stages, emphasizing early to growth-stage opportunities. Active across the biotechnology and healthcare sectors, they have executed over 30 deals, culminating in several notable exits in North America and Europe. Their strategic approach combines a data-driven investment philosophy with an operator-first mindset, enabling effective portfolio management and value creation. This blend of experience positions them as a key player in identifying transformative technologies and innovative solutions.